Q

Quince Therapeutics
D

QNCX

1.69000
USD
0.16
(10.46%)
Market Closed
Volume
6,019
EPS
0
Div Yield
0
P/E
-1
Market Cap
73,137,464
News

Title: Quince Therapeutics

Sector: Healthcare
Industry: Biotechnology
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.